Continue to Innovate Services, Therapies and Products
Vaccines Sales Goal ? $1 Billion by 2010
BioScience Vaccines portfolio:
- Unique technology platforms (cell culture /carbohydrate / protein conjugation / recombinant proteins and expression systems)
- Strong pipeline with focus on high growth potential targets
Future BioScience growth of vaccines will primarily be driven by areas of technological advantage
- Prophylactic vaccines such as Meningitis, Traveler’s and other infectious disease vaccines